III Congreso Anual de Ictus
7-9 de octubre de 2024, Barcelona
Del 7 al 9 de octubre de 2025 celebramos el III Congreso Anual de Ictus en el Hospital Universitario Vall d´Hebrón de Barcelona con las asistencia de 161 personas.
El congreso constó de dos partes; los días 7 y 8 de octubre: New insights and perspectives on intracerebral hemorrhage, y el día 9 de octubre: Ischemic stroke meeting. Spanish Stroke Research Network.
A continuación se detalla el programa con las presentaciones de las que pudimos disfrutar:
NEW INSIGHTS AND PERSPECTIVES ON INTRACEREBRAL HEMORRHAGE: A COMPREHENSIVE UPDATE
7 de octubre:
18:30 – State of the art in intracerebral hemorrhage management and impact on global health, Nikola Sprigg
8 de octubre:
8:45 a.m. Welcome and Opening Remark Ignacio Lizasoain
Begoña Benito Villabriga, Directora Institut de Recerca Vall d´Hebron
Session I-NOT ALL BLEEDINGS ARE EQUAL
9:00 – Is it important to correctly classify ICH? Joan Martí Fàbregas,
9:25 – Animal models of hemorrhage: challenges and successes. Cyrille Orset
9:50 – Emerging concepts in sporadic cerebral amyloid angiopathy. Francisco Hernández
10:15 – Abstract presentation
- Clinical Implications of the combination of etiologies in patients with ICH. Daniel Vázquez
- The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy. Mar Hernández
- Towards novel intracerebral haemorrhage stroke models by endovascular approach in swine 11. Teresa GasulL
- Study of MFG-E8 in experimental models of Cerebral Amyloid Angiopathy. Berta Páez
11:00 – Coffee Break
SESION II-TACKLING THE CONSEQUENCES OF INTRACEREBRAL HEMORRHAGE
11:30 – “Time is brain” also in hemorrhage [Hematoma expansion, care bundle, blood pressure reduction, hemostatic agents, neurosurgical treatment options, minimally invasive surgery]. David Rodríguez-Luna
11:55 – Novel targets and treatments for brain hemorrhage [Biological mechanisms associated peri-hematoma edema and brain injury, neuroprotective and neurorestoring agents]. Marietta Zille
12:20 – Antithrombotic treatment after ICH: harmful or beneficial? Rustam Al-Shahi Salman
12:45 – Abstract presentation
- Association between cerebral hemorrhage volume and acute hydrocephalus in aneurysmal subarachnoid hemorrhage: a semiautomatic measurement study. Laura Amaya
- Iron-free transferrin (apotransferrin) as a new treatment to improve stroke outcome in intracerebral hemorrhage. Teresa Gasull
- The proteome of Circulating Extracellular Vesicles as biomarkers of damage and repair in Intracerebral Hemorrhage. An approach to novel therapies? María Alonso de Leciñana
- Bacterial translocation after hemorrhagic stroke. Effect of the hematoma size and the absence of TLR4. Nuria Alfageme
13:30 – Lunch
SESSION III-WHAT BIOMARKERS BRING US
15:00 – Biological biomarkers: state of the art and usefulness, Mira Katan
15:25 – What is written in the genes. Jordi Jiménez
15:50 – Imaging biomarkers: what to look out for. Andrea Morotti
16:15 – Abstract presentation
- New Biomarkers in Predicting Intracerebral Hemorrhage Expansion: Cell-Free DNA. Levels and Noncontrast Computed Tomography Markers. Carla Vera
- A highly specific blood biomarkers panel to identify intracerebral hemorrhage at the ambulance might help to start pre-hospital blood-pressure reduction. Joan Montaner
- Multimodal imaging evaluation of the inflammatory response following experimental subarachnoid haemorrhage. Maider Garbizu
- Circulating mirnas as potential biomarkers of haematoma growth in intracerebral haemorrhage: a pilot study. María Lucas
17:00 – Coffee break
SESSION IV-FUTURE OF ICH
17:30 – How to manage uncertainty in decision making: prognostic models in ICH [Ethical issues in decision making, prognostic scales, predictive models, use of Artificial Intelligence]. Valeria Caso
17:55 – Update on ongoing clinical trials. Yolanda Silva
18:20 – Abstract presentation
- Circadian variation in clinical outcomes of intracerebral haemorrhage: the relevance of location. A retrospective study. María Esther Llorente
- Prognosis of Lobar Intracerebral Haemorrhage in Relation to Circulating Omega-3 Fatty Acids at Admission. Tomàs Xuclá
- p53 is involved in vascular damage and repair after hemorrhagic stroke. Cristina Rodriguez
19:05 – Closing Remarks, Mònica Millán, Hospital Germans Trias i Pujol (Spain)
19:15 – Final
SPANISH STROKE RESEARCH NETWORK MEETING
9 de octubre:
08:30 – 08:45: Welcome and Opening Remarks. Ignacio Lizasoain
08:45 – 09:05: 2022 Seed Fund: “Study of the role of RhoA and XDH proteins in mid intracerebral haemorrhage through the development of an in vitro model”. María Gutierrez
09:05 – 09:25: 2023 Seed Fund: “Neuromodulation of executive dysfunction by transcranial direct current stimulation in a rat model of cerebral infarction”. Patricia Martinez
09:25 – 09:45: 2024 Seed Fund: “Effect of TLR4-mediated modulation of inflammation on the reduction of brain damage after paediatric ischaemic stroke”. Macarena Hernández
09:45 – 10:05: RESEARCH LINE 1. BIOMARKERS. Summary of the main results of the “collaborative projects” Anna Rosell, Joan Montaner
10:05 – 10:35: Coffee break
10:35 – 10:55: RESEARCH LINE 2. ACUTE-PHASE TREATMENT. Summary of the main results of the “collaborative projects” Joan Martí, Natalia Pérez de Ossa,
10:55 – 11:15: RESEARCH LINE 3. CEREBROPOTECTION. Summary of the main results of the “collaborative projects” Angeles Almeida, Francisco Campos
11:15 – 11:35: RESEARCH LINE 4. BRAIN REPAIR AND FUNCTIONAL RECOVERY.. Summary of the main results of the “collaborative projects” Exuperio Diez-Tejedor, Mar Freijó
11:35 – 11:55: RESEARCH LINE 5. SECONDARY PREVENTION. Summary of the main results of the “collaborative projects” Mar Castellanos, Tomás Segura
11:55 – 12:30: DISCUSSION AND QUESTIONS
12:30 – 13:00: Closing Remarks and General Assembly
